This educational session focuses on recognizing the stages of imminent dying, managing symptoms, and addressing family concerns with empathy and clinical clarity.
Stages of Imminently Dying
- Early Stage (days to weeks): Patients become bedbound, stop eating/drinking, and may exhibit delirium or increased sleep. Pain often escalates.
- Middle Stage (days): Mental status worsens to obtundation, and secretions accumulate due to impaired swallowing and coughing reflexes.
- Late Stage (hours to days): Marked by altered respiratory patterns (e.g., apnea, mandibular breathing), cardiovascular collapse (hypotension, mottling), renal dysfunction (UOP <100cc/12h), and fever from aspiration.
Pain Assessment and Management at EOL
Pain is reported in ~80% of dying patients. Assessment must rely on nonverbal indicators such as restlessness, facial grimacing, or vital sign changes, as traditional pain scales are not validated in this population.
MOPAT (Multidimensional Objective Pain Assessment Tool) is validated for non-communicative, hospitalized palliative care patients. It includes a behavioral subscale (restlessness, muscle tension, facial expression, vocalization) and physiological subscale (heart rate, respirations, diaphoresis).
Respiratory Distress at End of Life
RDOS (Respiratory Distress Observation Scale) is a validated tool for assessing dyspnea in non-communicative patients. It incorporates eight indicators: Heart rate, Respiratory rate, Restlessness, Paradoxical breathing pattern, Grunting, Nasal flaring, Accessory muscle use, Facial expression of fear.
Special considerations include:
- Close monitoring for opioid toxicity due to hepatic/renal decline.
- Avoidance of oral opioids in obtunded patients; sublingual, rectal, or parenteral routes are preferred.
- Fentanyl patches are discouraged in acute EOL management due to delayed onset and reduced effectiveness in cachexia.
Symptom-Specific Management
| Symptom | Non-Rx Approaches | Pharmacologic Treatments |
| Weakness/Fatigue | Education, repositioning | Steroids (e.g., dexamethasone) |
| Anorexia | Education, avoid artificial feeding | Time-limited hydration if family insists |
| Delirium | Identify causes, minimize delirogens | Antipsychotics, benzodiazepines (newer data support benzos as first-line in some cases) |
| Secretions | Repositioning, limit fluids | Anticholinergics (e.g., glycopyrrolate, hyoscyamine) |
| Dyspnea | Education | Low-dose opioids |
| Fever | Cooling measures | Acetaminophen, NSAIDs if needed |